Pfizer, Eli Lilly And Bayer In Trouble With SCC

has proved to be immensely embarrassing for Pfizer, Eli Lilly and Bayer

Back in February Ukmedix News reported on the case that was initiated by The Swiss Competition Commission after they said that the retail prices of Viagra, Cialis and Levitra had been fixed by the local representatives of the respective drug companies Pfizer, Eli Lilly and Bayer AG.  Despite a vigorous defence by the drug companies The Swiss Competition Commission has found against them and they have been fined almost £4million. The press statement put out by the SCC did not specify the amount that each individual company had to pay but it is likely that the fines will be proportional to the sales of each respective drug company.

Pfizer hinted that they were not taking this decision lying down and said that the ruling from the SCC would “not survive a court examination” possibly meaning that they would now appeal to the Swiss legal establishment.  A spokeswoman from Eli Lilly said that they had priced their erectile dysfunction drug Cialis “in full compliance with Swiss competition law” and Bayer said that they were looking at legal ways to work out how they could not pay the fine.

This case has proved to be immensely embarrassing for Pfizer, Eli Lilly and Bayer and they are therefore likely to keep on fighting to the bitter end using every legal remedy at their disposal. The SCC had become suspicious after they claimed that the prices for all three of these impotence medications had risen drastically and the suggested prices from the drug companies were much too high. This case has been generating a huge amount of interest in Switzerland and will undermine the confidence that people have in drug companies there.

Viagra, Cialis and Levitra are the only three erectile dysfunction medications available to men suffering from vascular related erection problems.